Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city

Journal of Clinical Rheumatology

Volumn 14, Issue 3, 2008, Pages 153-155

  Caballero Uribe, Carlo V ^a,b   Acosta Velez, Juan G ^a   Hernandez Ruiz, Eder A ^a   Andrade Rodado, Fernando M ^a   Peñuela Epalza, Martha ^a  

^a UNIVERSIDAD DEL NORTE   (Colombia)

^b NONE   (Colombia)

Author keywords

Glucocorticoids; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; GLUCOCORTICOID; VITAMIN D; BONE DENSITY CONSERVATION AGENT;

ADULT; ARTICLE; COLOMBIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; DRUG INDUCED DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; MEDICAL AUDIT; MIDDLE AGED; MULTICENTER STUDY; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; RHEUMATIC DISEASE;

ABSORPTIOMETRY, PHOTON; BONE DENSITY CONSERVATION AGENTS; COLOMBIA; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; OSTEOPOROSIS; RHEUMATIC DISEASES;

EID: 48249135544     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31816b1931     Document Type: Article

References (20)

1. Sambrook PN. Corticoid osteoporosis: practical implications of recent trials. J Bone Miner Res. 2000;15:1645-1649.
2. Saag KG. Glucocorticoid-induced osteoporosis. End Metab Clin N Am. 2003;32:135-157.
3. Van Staa TP. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int. 2006;79:129- 137.
4. Walsh LJ, Wong CA, Pringle M, et al. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ. 1996;313:344-346.
5. Gudbjornsson B, Juliosson UI, Gudjonsson FV. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis. 2002;61:32-36.
6. Buckley LM, Marquez M, Hudson JO, et al. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician speciality. J Rheumatol. 1998;25:2195-2202.
7. Ramsey-Goldman R. Missed opportunities in physician management of glucocorticoid-induced osteoporosis? Arthritis Rheum. 2002;42:3115- 3130.
8. Yood RA, Harrold LR, Fish L, et al. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med. 2001;161:1332-1337.
9. American Collage of Rheumatology Ad Hoc Committee on Glucocortocoid Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum. 2001;44:1496-1503.
10. Solomon DH, Katz JN, Jacobs JP, et al. Management of glucocorticoid- induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in academic rheumatology practice. Arthritis Rheum. 2002;46:3136-3142.
11. Erb N, Duncan RC, Rowe IF, et al. A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands. Rheumatology. 2002;4:1021- 1024.
12. Saag KG, Gehlbach SH, Curtis JR, et al. Trends in prevention of glucocorticoid-induced osteoporosis. J Rheumatol. 2006;33:1651-1657.
13. Patel R, Blake GM, Fogelman I. An evaluation of the United Kingdom National Osteoporosis Society position statement on the use of peripheral dual-energy X-ray absorptiometry. Osteoporos Int. 2004;15:497- 504.
14. Picard D, Brown JP, Rosenthall L, et al. Ability of peripheral DXA measurement to diagnose osteoporosis as assessed by central DXA measurement. J Clin Densitom. 2004;7:111-118.
15. Devogelaer JP, Goemaere S, Boonen S, et al. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int. 2006;17:8-19.
16. Sambrook PN, Kotowicz M, Nash P, et al. Prevention and treatment of osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J Bone Miner Res. 2003;18:919-924.
17. Buckley LM, Hillner BE. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids. J Rheumatol. 2003;30:132-138.
18. ISSN 0121-4675 Res. MinGobierno 0036/91 Año 16 Nro. 35/2006 Bogotá, 30 de agosto de 2006-.
19. Yood RA. Prevention of glucocorticoid induced osteoporosis. Why are we doing so poorly? J Rheumatol. 2006;33:1461-1463.
20. First Latin-American Position paper on the Pharmacological treatment of Rheumatoid Arthritis. Rheumatology. 2006;45:(suppl 2):ii7-ii22(1).